参考文献/References:
［1］子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识 ［J］. 中华妇产科杂志, 2017, 52 (12): 793-800.
［2］Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas ［J］. Fertil Steril,2007, 87 (4):725-736.
［3］DiSpiezioSardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques ［J］. Hum Reprod Update, 2008, 14 (2): 101-119.
［4］Munro MG,Critchley HO,Fraser IS, et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years ［J］.Fertil Steril, 2011, 95 (7): 2204-2208, 2208.e1-e3.
［5］Patil SG,Bhute SB,Inamdar SA, et al. Role of diagnostic hysteroscopy in abnormal uterine bleeding and its histopathologic correlation ［J］. J Gynecol Endosc Surg,2009, 1 (2): 98-104.
［6］Mazzon I,Favilli A,Grasso M, et al. Is cold loop hysteroscopic myomectomy a safe and effective technique for the treatment of submucous myomas with intramural development? A series of 1434 surgical procedures ［J］.J Minim Invasive Gynecol,2015, 22 (5): 792-798.
［7］Muoz JL,Jiménez JS,Hernández C, et al. Hysteroscopic myomectomy: our experience and review ［J］. JSLS,2003,7 (1): 39-48.
［8］Yang JH,Chen MJ,Chen CD, et al. Impact of submucous myoma on the severity of anemia ［J］. Fertil Steril,2011, 95 (5):1769-1772.e1.
［9］Pritts EA, Parker WH, Olive DL.Fibroids and infertility: an updated systematic review of the evidence ［J］. Fertil Steril, 2009, 91 (4): 1215-1223.
［10］张颖，段华. 子宫内膜-肌层交界区的生理功能与相关疾病 ［J］. 中华妇产科杂志, 2009, 44 (11): 876-878.
［11］Cholkeri-Singh A, Sasaki KJ. Hysteroscopy for infertile women: a review ［J］. J Minim Invasive Gynecol, 2015, 22 (3): 353-362.
［12］Capmas P,Levaillant JM,Fernandez H. Surgical techniques and outcome in the management of submucous fibroids ［J］. Curr Opin Obstet Gynecol,2013, 25 (4): 332-338.
［13］Casadio P, Guasina F, Morra C, et al. Hysteroscopic myomectomy: techniques and preoperative assessment ［J］.Minerva Ginecol，2016，68 (2):154-166.
［14］Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids ［J］.Best Pract Res ClinObstetGynaecol. 2016, 34:74-84.
［15］Abdusattarova K, Mettler L, Alkatout I, et al. Endoscopic treatment of symptomatic fibroids at reproductive age and beyond ［J］. Minim Invasive Ther Allied Technol， 2017, 26 (6): 355-361.
［16］Zayed M, Fouda UM, Zayed SM, et al. Hysteroscopic Myomectomy of Large Submucous Myomas in a 1-Step Procedure Using Multiple Slicing Sessions Technique ［J］. J Minim Invasive Gynecol, 2015, 22 (7):1196-1202.
［17］Varma R,Soneja H,Clark TJ, et al. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up ［J］. Eur J Obstet Gynecol Reprod Biol,2009, 142 (2): 154-159.
［18］Shokeir T,El-Shafei M,Yousef H, et al. Submucous myomas and their implications in the pregnancy rates of patients with otherwise unexplained primary infertility undergoing hysteroscopic myomectomy: a randomized matched control study ［J］. Fertil Steril,2010, 94 (2): 724-729.
［19］Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility ［J］. Arch Gynecol Obstet, 2005, 273 (1): 50-54.
［20］Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline ［J］. Fertil Steril，2017, 108 (3): 416-425.
［21］Yang JH,Chen MJ,Chen CD, et al. Optimal waiting period for subsequent fertility treatment after various hysteroscopic surgeries ［J］. Fertil Steril,2013, 99 (7): 2092-2096.
［22］Yang JH, Chen MJ, Wu MY, et al. Office hysterscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas ［J］.Fertil Steril, 2008,89(5):1254-1259.
［23］郎景和, 石一复，王智彪. 子宫肌瘤 ［M］.北京：人民卫生出版社, 2014:141-149.
［24］Capmas P, Voulgaropoulos A, Legendre G, et al. Hysteroscopic resection of type 3 myoma: a new challenge? ［J］ Eur J Obstet Gynecol Reprod Biol，2016, 205:165-169.
［25］Muzii L,Boni T,Bellati F, et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study ［J］. Fertil Steril,2010, 94 (4):1496-1499.
［26］Mencaglia L, Tantini C. GnRH agonist analogs and hysteroscopic resection of myomas ［J］. Int J Gynaecol Obstet, 1993, 43 (3): 285-288.
［27］Zhang Y,Sun L,Guo Y, et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis ［J］. Obstet Gynecol Surv, 2014, 69(2): 100-108.
［28］Tan YH,Lethaby A. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding ［J］.Cochrane Database Syst Rev，2013, 11:CD010241.
［29］Mavrelos D, Ben-Nagi J, Davies A, et al. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial ［J］. Hum Reprod,2010, 25 (9):2264-2269.
［30］Kamath MS,Kalampokas EE,Kalampokas TE. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis ［J］. Eur J Obstet Gynecol Reprod Biol, 2014, 177（2）:11-18.
［31］Duhan N. Current and emerging treatments for uterine myoma-an update ［J］.Int J Womens Health,2011, 3: 231-241.
［32］Kodama M1, Onoue M, Otsuka H, et al. Efficacy of dienogest in thinning the endometrium before hysteroscopic surgery ［J］. J Minim Invasive Gynecol,2013, 20 (6):790-795.
［33］Wong AS, Cheung CW, Yeung SW, et al. Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: a randomized controlled trial ［J］. Obstet Gynecol,2014, 124 (5): 897-903.
［34］Sancho JM, Delgado VS, Valero MJ, et al. Hysteroscopic myomectomy outcomes after 3-month treatment with either Ulipristal Acetate or GnRH analogues: a retrospective comparative study ［J］.Eur J Obstet Gynecol Reprod Biol，2016, 198:127-130.
［35］Saccardi C,Conte L,Fabris A, et al. Hysteroscopic enuleation in toto of submucous type 2 myomas:long-term follow-up in women affected by menorrhagia ［J］. J Minim Invasive Gynecol,2014, 21 (3): 426-430.
［36］Litta P, Leggieri C,Conte L, et al. Monopolar versus bipolar device: safety, feasibility, limits and perioperative complications in performing hysteroscopic myomectomy ［J］. Clin Exp Obstet Gynecol,2014, 41 (3): 335-338.
［37］Camanni M, Bonino L, Delpiano EM, et al. Hysteroscopic management of large symptomatic submucous uterine myomas ［J］. J Minim Invasive Gynecol,2010, 17(1):59-65.
［38］Litta P,Vasile C, Merlin F, et al. A new technique of hysteroscopic myomectomy with enucleation in toto ［J］.J Am Assoc Gynecol Laparosc,2003, 10 (2): 263-270.
［39］Vitale SG, Sapia F, Rapisarda AMC, et al. HysteroscopicMorcellation of SubmucousMyomas: A Systematic Review ［J］. Biomed Res Int, 2017,2017:6848250.
［40］Lee MM, Matsuzono T. Hysteroscopic intrauterine morcellation of submucosal fibroids: preliminary results in Hong Kong and comparisons with conventional hysteroscopicmonopolar loop resection ［J］.Hong Kong Med J，2016, 22(1):56-61.
［41］Arnold A, Ketheeswaran A, Bhatti M, et al.A prospective analysis of hysteroscopicmorcellation in the management of intrauterine pathologies ［J］.Journal of Minimally Invasive Gynecology，2016, 23 (3):435–441.
相似文献/References:
[1]党蓉芳,薛晓玲,张永利,等.应用宫腔镜诊治绝经后子宫出血109例临床分析[J].中国计划生育和妇产科,2009,(05):0.
DANG Rong-fang,XUE Xiao-ling,ZHANG Yong-li,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(11):0.
[2]杨学妞.难取节育器36例的处理及分析[J].中国计划生育和妇产科,2009,(05):0.
[3]沈山,高李英.宫腔镜在宫内节育器常规取出失败后的应用[J].中国计划生育和妇产科,2010,(05):0.
SHEN Shan,GAO Li-ying.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[4]卢春梅,邱艳.宫腔镜对子宫纵隔的诊疗分析[J].中国计划生育和妇产科,2010,(06):0.
LU Chun-mei,QIU Yan.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(11):0.
[5]张永利,郭君丽.重度宫腔粘连宫腔镜分离术后防止宫腔再粘连方法的比较[J].中国计划生育和妇产科,2011,(06):0.
ZHANG Yong-li,GUO Jun-li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(11):0.
[6]段华.子宫肌瘤宫、腹腔镜诊疗现状与进展[J].中国计划生育和妇产科,2012,(03):0.
DUAN Hua Biijing Obstetrics and Gynecology Hospital,Capital uedical Vniversity,Beijing 0000,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(11):0.
[7]何玉萍,孙佳玉,杨小平,等.米索前列醇联合B超在扩宫失败患者中的应用观察[J].中国计划生育和妇产科,2012,(05):0.
HE Yu-ping,SUN Jia-yu,YANG Xiao-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(11):0.
[8]姜桂芳.宫腔镜诊治不孕症女性子宫腔内病变600例临床分析[J].中国计划生育和妇产科,2013,(02):0.
JIANG Gui-fang,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[9]黄海霞,周敏,祝昭惠,等.甲氨蝶呤联合宫腹腔镜监测行刮宫术治疗早期剖宫产瘢痕妊娠21例分析[J].中国计划生育和妇产科,2013,(04):0.
HUANG Hai-xia *,ZHOU Min,ZHU Zhao-hui,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.
[10]汪沙,段华,付凤仙,等.卡前列甲酯用于子宫腔疾病诊断术前宫颈预处理的疗效观察[J].中国计划生育和妇产科,2013,(05):0.
WANG Sha,DUAN Hua,FU Feng-xian,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(11):0.